Abstract
NK4, composed of the N-terminal hairpin and subsequent four-kringle domains of hepatocyte growth factor (HGF), acts not only as a competitive antagonist for HGF but also as a potent angiogenesis inhibitor. This study was designed to assess a therapeutic potential of adenovirus-mediated NK4 gene transfer for disseminated pancreatic cancer cells in the peritoneal lavage of nude mice. We constructed a recombinant adenovirus NK4 (Ad-NK4), which encodes a secretable form of human NK4. In vitro migration of AsPC-1 (human pancreatic cancer cell line) was stimulated by HGF, and it was completely inhibited by Ad-NK4 transfection. Weekly intraperitoneal injections of Ad-NK4 could suppress the development of tumor nodules in a nude mouse peritoneal dissemination model. NK4 expression was detected in the disseminated nodules, liver, pancreas, spleen, and mesenterium. Immunohistochemical study of the disseminated tumors showed a remarkable decrease in microvessel density and an increase in number of apoptotic tumor cells in the Ad-NK4–treated mice. Survival of the Ad-NK4–treated mice was significantly improved. This study indicates that the intraperitoneal transduction of adenovirus-mediated NK4 gene may be a useful therapeutic modality to prevent the development of peritoneal dissemination of pancreatic cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gunzburg WH, Salmons B . Novel clinical strategies for the treatment of pancreatic carcinoma Trends Mol Med 2001 7: 30–37 Review
Niederhuber JE, Brennan MF, Menck HR . The National Cancer Data Base report on pancreatic cancer Cancer 1995 76: 1671–1677
Warshaw AL, Fernandez-del Castillo C . Pancreatic carcinoma N Engl J Med 1992 326: 455–465
Henne-Bruns D, Vogel I, Luttges J, Klöppel G, Kremer B . Ductal adenocarcinoma of the pancreas head: survival after regional versus extended lymphadenectomy Hepatogastroenterology 1998 45: 855–866
Vogel I, Kruger U, Marxsen J et al. Disseminated tumor cells in pancreatic cancer patients detected by immunocytology: a new prognostic factor Clin Cancer Res 1999 5: 593–599
Neoptolemos JP, Dunn JA, Stocken DD et al. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial Lancet 2002 358: 1576–1585
Schmiegel W, Schmielau J, Henne-Bruns D et al. Cytokine-mediated enhancement of epidermal growth factor receptor expression provides an immunological approach to the therapy of pancreatic cancer Proc Natl Acad Sci USA 1997 94: 12622–12626
Simeone DM, Cascarelli A, Logsdon CD . Adenoviral-mediated gene transfer of a constitutively active retinoblastoma gene inhibits human pancreatic tumor cell proliferation Surgery 1997 122: 428–433 discussion 433–434
Nakamura T, Nawa K, Ichihara A . Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats Biochem Biophys Res Commun 1984 122: 1450–1459
Nakamura T, Nishizawa T, Hagiya M et al. Molecular cloning and expression of human hepatocyte growth factor Nature 1989 342: 440–443
Matsumoto K, Nakamura T . Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration Biochem Biophys Res Commun 1997 239: 639–644
Birchmeier C, Gherardi E . Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase Trends Cell Biol 1998 8: 404–410
Zarnegar R, Michalopoulos GK . The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis J Cell Biol 1995 129: 1177–1180
Nakamura T, Matsumoto K, Kiritoshi A, Tano Y . Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor–stromal interactions Cancer Res 1997 57: 3305–3313
Seslar SP, Nakamura T, Byers SW . Regulation of fibroblast hepatocyte growth factor/scatter factor expression by human breast carcinoma cell lines and peptide growth factors Cancer Res 1993 53: 1233–1238
Di Renzo MF, Poulsom R, Olivero M, Comoglio PM, Lemoine NR . Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer Cancer Res 1995 55: 1129–1138
Maehara N, Matsumoto K, Kuba K, Mizumoto K, Tanaka M, Nakamura T . NK4, a four-kringle antagonist of HGF, inhibits spreading and invasion of human pancreatic cancer cells Br J Cancer 2001 84: 864–873
Date K, Matsumoto K, Kuba K, Shimura H, Tanaka M, Nakamura T . Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor Oncogene 1998 17: 3045–3054
Date K, Matsumoto K, Shimura H, Tanaka M, Nakamura T . HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor FEBS Lett 1997 420: 1–6
Matsumoto K, Kataoka H, Date K, Nakamura T . Cooperative interaction between alpha-and beta-chains of hepatocyte growth factor on c-Met receptor confers ligand-induced receptor tyrosine phosphorylation and multiple biological responses J Biol Chem 1998 273: 22913–22920
Kuba K, Matsumoto K, Date K, Shimura H, Tanaka M, Nakamura T . HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice Cancer Res 2000 60: 6737–6743
Tomioka D, Maehara N, Kuba K et al. Inhibition of growth, invasion, and metastasis of human pancreatic carcinoma cells by NK4 in an orthotopic mouse model Cancer Res 2001 61: 7518–7524
Maemondo M, Narumi K, Saijo Y et al. Targeting angiogenesis and HGF function using an adenoviral vector expressing the HGF antagonist NK4 for cancer therapy Mol Ther 2002 5: 177–185
McGrory WJ, Bautista DS, Graham FL . A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5 Virology 1988 163: 614–617
Korst RJ, Bewig B, Crystal RG . In vitro and in vivo transfer and expression of human surfactant SP-A– and SP-B–associated protein cDNAs mediated by replication-deficient, recombinant adenoviral vectors Hum Gene Ther 1995 6: 277–287
Yashiro M, Chung YS, Inoue T et al. Hepatocyte growth factor (HGF) produced by peritoneal fibroblasts may affect mesothelial cell morphology and promote peritoneal dissemination Int J Cancer 1996 67: 289–293
Vande Woude GF, Jeffers M, Cortner J, Alvord G, Tsarfaty I, Resau J . Met-HGF/SF: tumorigenesis, invasion and metastasis Ciba Found Symp 1997 212: 119–130 discussion 130–132, 148–154
Jiang W, Hiscox S, Matsumoto K, Nakamura T . Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer Crit Rev Oncol Hematol 1999 29: 209–248
Furukawa T, Duguid WP, Kobari M, Matsuno S, Tsao MS . Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesis Am J Pathol 1995 147: 889–895
Ebert M, Yokoyama M, Friess H, Buchler MW, Korc M . Coexpression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer Cancer Res 1994 54: 5775–5778
Paciucci R, Vila MR, Adell T et al. Activation of the urokinase plasminogen activator/urokinase plasminogen activator receptor system and redistribution of E-cadherin are associated with hepatocyte growth factor–induced motility of pancreas tumor cells overexpressing Met Am J Pathol 1998 153: 201–212
Folkman J . Angiogenesis in cancer, vascular, rheumatoid and other disease Nat Med 1995 1: 27–31
Ikeda N, Adachi M, Taki T et al. Prognostic significance of angiogenesis in human pancreatic cancer Br J Cancer 1999 79: 1553–1563
Kawarada Y, Ishikura H, Kishimoto T et al. Inhibitory effects of the antiangiogenic agent TNP-470 on establishment and growth of hematogenous metastasis of human pancreatic carcinoma in SCID beige mice in vivo Pancreas 1997 15: 251–257
Bruns CJ, Solorzano CC, Harbison MT et al. Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma Cancer Res 2000 60: 2926–2935
Schwarte-Waldhoff I, Volpert OV, Bouck NP et al. Smad4/DPC4–mediated tumor suppression through suppression of angiogenesis Proc Natl Acad Sci USA 2000 97: 9624–9629
Kuba K, Matsumoto K, Ohnishi K, Shiratsuchi T, Tanaka M, Nakamura T . Kringle 1–4 of hepatocyte growth factor inhibits proliferation and migration of human microvascular endothelial cells Biochem Biophys Res Commun 2000 279: 846–852
Kozarsky KF, Wilson JM . Gene therapy: adenovirus vectors Curr Opin Genet Dev 1993 3: 499–503
Grace MJ, Xie L, Musco ML et al. The use of laser scanning cytometry to assess depth of penetration of adenovirus p53 gene therapy in human xenograft biopsies Am J Pathol 1999 155: 1869–1878
Acknowledgements
We thank Shoko Nishio for her excellent technical assistance. This study was supported, in part, by Grant-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan; Pancreas Research Foundation of Japan; and Kyushu University Interdisciplinary Programs in Education and Projects in Research Development. A part of the study was carried out at the Morphology Core, Graduate School of Medical Sciences, Kyushu University.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Saimura, M., Nagai, E., Mizumoto, K. et al. Intraperitoneal injection of adenovirus-mediated NK4 gene suppresses peritoneal dissemination of pancreatic cancer cell line AsPC-1 in nude mice. Cancer Gene Ther 9, 799–806 (2002). https://doi.org/10.1038/sj.cgt.7700504
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cgt.7700504
Keywords
This article is cited by
-
Sirt1 AS lncRNA interacts with its mRNA to inhibit muscle formation by attenuating function of miR-34a
Scientific Reports (2016)
-
A clinical protocol to inhibit the HGF/c-Met pathway for malignant mesothelioma with an intrapleural injection of adenoviruses expressing the NK4 gene
SpringerPlus (2015)
-
Ectopic expression of RBP4 impairs the insulin pathway and inguinal fat deposition in mice
Journal of Physiology and Biochemistry (2014)
-
Engineering of magnetic DNA nanoparticles for tumor-targeted therapy
Journal of Nanoparticle Research (2013)
-
Adeno-associated virus-mediated delivery of kringle 5 of human plasminogen inhibits orthotopic growth of ovarian cancer
Gene Therapy (2010)